BGLC
BASIC MATERIALSBioNexus Gene Lab Corp
$2.00-0.04 (-1.91%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving BGLC Today?
No stock-specific AI insight has been generated for BGLC yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$1.92$15.60
$2.00
Fundamentals
Market Cap$5M
P/E Ratio—
EPS$-1.61
Dividend Yield—
Dividend / Share—
ROE-0.4%
Profit Margin-0.4%
Debt / Equity—
Trading
Volume4K
Avg Volume (10D)—
Shares Outstanding2.4M
BGLC News
12 articles- BioNexus Gene Lab Corp. Announces Appointment of Dr. Muthu Meyyappan as Chief Commercial Officer of Fidelion Diagnostics to Lead Global Commercialization of the VitaGuard™ MRD PlatformYahoo Finance·Mar 11, 2026
- BioNexus Gene Lab Corp. Completes Chemrex Governance Restructuring; Appoints Matthew Barsing as ChairmanYahoo Finance·Feb 23, 2026
- BioNexus Launches Regional Deployment of VitaGuard™ MRD Infrastructure; Positioned to Challenge Legacy Oncology Platforms Across ASEAN’s Multi-Billion Dollar MarketYahoo Finance·Jan 28, 2026
- BioNexus Gene Lab Corp. Completes Strategic Investment in Fidelion Diagnostics; Secures 15% Equity Stake in Global AI-Oncology Platform and Exclusive Southeast Asian Rights for VitaGuard™Yahoo Finance·Dec 3, 2025
- BioNexus Gene Lab Corp. (Nasdaq: BGLC) Secures $500 Million Equity Facility From ARC Group International to Support Expansion of Precision Diagnostics, CDMO Operations, and Therapeutic CommercializationYahoo Finance·Dec 2, 2025
- BioNexus Gene Lab Corp. (Nasdaq: BGLC) and Fidelion Diagnostics Execute Exclusive Southeast Asia License for VitaGuard™ MRD Platform as Part of Strategic Alliance with Tongshu GeneYahoo Finance·Dec 1, 2025
- BioNexus Gene Lab Corp. (Nasdaq: BGLC) Announces Strategic Agreements with Fidelion Diagnostics for Southeast Asia MRD CommercializationYahoo Finance·Nov 12, 2025
- BioNexus Gene Lab Corp. Files $100 Million Shelf Registration and Establishes $20 Million At-the-Market Program to Advance Strategic Growth OpportunitiesYahoo Finance·Nov 10, 2025
- Top Midday GainersYahoo Finance·Jul 30, 2025
- BioNexus Gene Lab Corp. and Fidelion Diagnostics Announce Landmark Alliance—Touted as a new “DeepSeek Moment” in Precision OncologyYahoo Finance·Jul 30, 2025
- Wall Street Set to Open Lower Wednesday as Jobs Data Misses ForecastsYahoo Finance·Jul 2, 2025
- US Futures Subdued as Investors Eye Key Employment DataYahoo Finance·Jul 2, 2025
All 12 articles loaded
Price Data
Open$2.11
Previous Close$2.04
Day High$2.11
Day Low$2.00
52 Week High$15.60
52 Week Low$1.92
52-Week Range
$1.92$15.60
$2.00
Fundamentals
Market Cap$5M
P/E Ratio—
EPS$-1.61
Dividend Yield—
Dividend / Share—
ROE-0.4%
Profit Margin-0.4%
Debt / Equity—
Trading
Volume4K
Avg Volume (10D)—
Shares Outstanding2.4M
About BioNexus Gene Lab Corp
BioNexus Gene Lab Corp. The company is headquartered in Kuala Lumpur, Malaysia.
BASIC MATERIALSSPECIALTY CHEMICALS
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICSPECIALTY CHEMICALS
CIK—
Composite FIGI—
Share Class FIGI—